Neurocutaneous Melanocytosis-Associated Hydrocephalus: The Memorial Sloan Kettering Experience from 2001 to 2022.

Autor: Rodriguez S; Deaprtment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., DeIeso-Frechette F; Deaprtment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Umeasor C; Deaprtment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Alli C; Deaprtment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Azzi C; Deaprtment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Haque S; Deaprtment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Deaprtment of Pediatrics, New York-Presbyterian: Weill Cornell Medical Center, New York, New York, USA., Pugh JA; Deaprtment of Pediatrics, Albany Medical Center, Albany, New York, USA., Meeker N; Deaprtment of Pediatrics, St. Luke's Children's Cancer Institute, Boise, Idaho, USA., Khakoo Y; Deaprtment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Deaprtment of Pediatrics, New York-Presbyterian: Weill Cornell Medical Center, New York, New York, USA.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Nov 06, pp. e31434. Date of Electronic Publication: 2024 Nov 06.